Priorities for a New FDA

This Viewpoint outlines new priorities of the US Food and Drug Administration (FDA).

martedì 10 giugno 2025 New tab

3,080 words~14 min read

Home | JAMA | New Online

Viewpoint

Priorities for a New FDA

Martin A. Makary, MD, MPH1; Vinay Prasad, MD, MPH1

Author Affiliations Article Information

Other newsrooms on this story

· 4 sources

· 4 sources

Leaders of the FDA have published a list of new priorities for the agency. They want to deliver rapidly-approved cures and…

technologyreview.com11 mesi fa

What Marty Makary's successor can learn from his mistakes.

washingtonpost.com21 h fa

Makary helms the FDA in the midst of a contentious stretch for the agency, defined by massive staff and budget cuts and sweeping…

cnbc.com2 mesi fa

Makary pointed to three bottlenecks: hospital contracting, ethical reviews and approvals and the Investigational New Drug…

cnbc.com2 mesi fa

U.S. Food and Drug Administration Commissioner Marty Makary, under pressure, defends himself in an interview with CNBC's David…

cnbc.com9 g fa

They called for stability and predictability at the agency at Axios' Future of Health summit.

axios.com21 h fa